ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
Annals of Oncology
◽
10.1093/annonc/mdp328
◽
2010
◽
Vol 21
(3)
◽
pp. 493-497
◽
Cited By ~ 9
Author(s):
W.W. Tan
◽
D.W. Hillman
◽
M. Salim
◽
D.W. Northfelt
◽
D.M. Anderson
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Metastatic Breast
◽
Phase 2
◽
North Central
◽
Irinotecan Hydrochloride
◽
Phase 2 Trial
Download Full-text
Related Documents
Cited By
References
Correction to: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
Annals of Oncology
◽
10.1093/annonc/mdx811
◽
2018
◽
Vol 29
(10)
◽
pp. 2150
Author(s):
W.W. Tan
◽
D.W. Hillman
◽
M. Salim
◽
D.W. Northfelt
◽
D.M. Anderson
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Metastatic Breast
◽
Phase 2
◽
North Central
◽
Irinotecan Hydrochloride
◽
Phase 2 Trial
Download Full-text
Faculty of 1000 evaluation for N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718023021.793480259
◽
2013
◽
Author(s):
Ana Maria Gonzalez-Angulo
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Aromatase Inhibitor
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
North Central
◽
Previously Treated
Download Full-text
North Central Cancer Treatment Group N0531: Phase II Trial of Weekly Albumin-Bound Paclitaxel (ABI-007; Abraxane®) in Combination with Gemcitabine in Patients with Metastatic Breast Cancer
Clinical Breast Cancer
◽
10.3816/cbc.2005.n.042
◽
2005
◽
Vol 6
(4)
◽
pp. 361-364
◽
Cited By ~ 13
Author(s):
Alvaro Moreno-Aspitia
◽
Edith A. Perez
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
North Central
Download Full-text
North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Annals of Oncology
◽
10.1093/annonc/mdp512
◽
2010
◽
Vol 21
(2)
◽
pp. 269-274
◽
Cited By ~ 23
Author(s):
E.A. Perez
◽
D.W. Hillman
◽
T. Dentchev
◽
N.A. Le-Lindqwister
◽
L.H. Geeraerts
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
North Central
◽
Line Chemotherapy
Download Full-text
North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane
Clinical Breast Cancer
◽
10.1016/j.clbc.2012.09.007
◽
2012
◽
Vol 12
(6)
◽
pp. 387-391
◽
Cited By ~ 13
Author(s):
Kostandinos Sideras
◽
Amylou C. Dueck
◽
Timothy J. Hobday
◽
Kendrith M. Rowland
◽
Jacob B. Allred
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
North Central
◽
Previously Treated
◽
Vegf Trap
Download Full-text
Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer a collaborative north central cancer treatment group/mayo clinic phase ii study
Cancer
◽
10.1002/1097-0142(19900201)65:3<418::aid-cncr2820650307>3.0.co;2-k
◽
1990
◽
Vol 65
(3)
◽
pp. 418-421
◽
Cited By ~ 17
Author(s):
James E. Krook
◽
Charles L. Loprinzi
◽
Daniel J. Schaid
◽
Carl G. Kardinal
◽
James A. Mailliard
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Continuous Infusion
◽
Phase Ii
◽
Mayo Clinic
◽
Phase Ii Study
◽
Metastatic Breast
◽
North Central
Download Full-text
N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial
Annals of Oncology
◽
10.1093/annonc/mdt213
◽
2013
◽
Vol 24
(10)
◽
pp. 2548-2554
◽
Cited By ~ 7
Author(s):
W.W. Tan
◽
A.C. Dueck
◽
P. Flynn
◽
P. Steen
◽
D. Anderson
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Aromatase Inhibitor
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
North Central
◽
Previously Treated
Download Full-text
N0539 Phase II Trial of Fulvstrant and Bevacizumab in Patients with Metastatic Breast Cancer Previously Treated with an Aromatase Inhibitor: A North Central Cancer Treatment Group Trial.
10.1158/0008-5472.sabcs-09-4096
◽
2009
◽
Cited By ~ 1
Author(s):
W. Tan
◽
A. Dueck
◽
P. Flynn
◽
P. Steen
◽
D. Anderson
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Aromatase Inhibitor
◽
Phase Ii Trial
◽
Metastatic Breast
◽
North Central
◽
Previously Treated
◽
Group Trial
Download Full-text
Comparison of binary efficacy endpoints in 11 North Central Cancer Treatment Group phase II metastatic breast cancer clinical trials.
10.1158/0008-5472.sabcs-6147
◽
2009
◽
Author(s):
AC Dueck
◽
DW Hillman
◽
H Liu
◽
KM Rowland
◽
FM Palmieri
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trials
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Phase Ii
◽
Metastatic Breast
◽
Cancer Clinical Trials
◽
North Central
Download Full-text
Clinical characteristics, univariate, and multivariate Cox model analysis of long-term (> 3 years) survivors of stage IV metastatic breast cancer treated on phase II or III North Central Cancer Treatment Group (NCCTG) trials.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.1157
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 1157-1157
Author(s):
T. A. Patel
◽
H. Liu
◽
D. W. Hillman
◽
A. C. Dueck
◽
J. N. Ingle
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Treatment Group
◽
Cancer Treatment
◽
Clinical Characteristics
◽
Cox Model
◽
Metastatic Breast
◽
Stage Iv
◽
North Central
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close